Get the Daily Brief
Latest Biotech News
EMA Advances Multiple Orphan Drugs Amid Alzheimer’s and HIV Decisions
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) recently issued several decisions, approving five orphan drugs including Eli Lilly’s Alzheimer’s therapy...
Leads Biolabs Surges in Hong Kong IPO as China Antibody Developer
Chinese biotech Leads Biolabs soared nearly 100% on its first trading day following a HK$1.3 billion ($189 million) initial public offering on the Hong Kong Stock Exchange. The company specializes...
AI Advances Personalized T Cell Therapies and Protein Design
Innovation at the intersection of AI and immunology is accelerating personalized cancer treatment. New computational tools like BATMAN outperform existing models in predicting T cell receptor...
Significant Biopharma Funding Rounds and Venture Capital Trends
Several biotech-focused venture firms have closed large fundraising rounds, reflecting sustained, though selective, investor interest. Omega Funds announced a $647 million eighth fund, nearly...
AI and Computational Biology Unlock Insights into Proteomics and Genomics
Recent computational advances enable novel insights into human biology and disease. A new plain-language 'hypothesis grammar' framework predicts cell activity in tissues, bridging biology and...
Bristol Myers Squibb Names AstraZeneca’s Cristian Massacesi as CMO
Bristol Myers Squibb announced the appointment of Cristian Massacesi, former chief medical officer at AstraZeneca and its Alexion unit, as its new chief medical officer starting August 1....
Regulatory and Clinical Updates across Med-Tech and Biopharma
Several regulatory and clinical events mark ongoing industry progress. The FDA approved Leo Pharma’s topical cream, Anzupgo, for chronic hand eczema—the first approved treatment for this...
Deloitte Survey Highlights Life Sciences Tariff and Pricing Challenges
A recent Deloitte survey of 120 global healthcare and life sciences executives exposes significant uncertainty stemming from tariffs and pricing policy shifts impacting long-term commercial...
Sarepta's Duchenne Gene Therapy Crisis Deepens
European regulators rejected Sarepta Therapeutics' Duchenne muscular dystrophy gene therapy Elevidys, citing insufficient evidence of efficacy, which majorly threatens the drug's future....
AI Advances in Immunotherapy and Protein Design
Artificial intelligence is increasingly harnessed to improve immunotherapy and protein engineering. Researchers developed BATMAN, a Bayesian model trained on a comprehensive T cell...
Bristol Myers Names New Chief Medical Officer from AstraZeneca
Bristol Myers Squibb appointed Cristian Massacesi, former chief medical officer at AstraZeneca and Alexion, as its new CMO effective August 1. Massacesi replaces Samit Hirawat who oversaw the...
FDA and EMA Regulatory Delays and Decisions
The FDA delayed approval of Bayer's non-hormonal menopause therapy elinzanetant by up to three months, citing additional review needs. Similarly, the EMA's Committee for Medicinal Products for...
Genomics and Multiomics Research Progress
Recent advances in genomics and multiomics are reshaping understanding of biology and disease. The 1000 Genomes Project Long-Read Sequencing Consortium expanded efforts by adding PacBio sequencing...
Biopharma Fundraising and Market Trends
The biopharma sector shows mixed market signals amid fundraising and restructurings. Australian venture firm Brandon Capital closed its sixth fund at AU$439 million, the largest to date,...
Innovations in Diagnostic and Sequencing Technologies
Technological advances continue to enhance diagnostics and sequencing capabilities. Qiagen released a long-read target enrichment panel compatible with multiple NGS platforms for detailed genetic...
Med-Tech and Device Regulatory Updates and Market Moves
Recent med-tech developments include regulatory designations and market performance shifts. Cryofocus received FDA breakthrough device designation for its asthma cryoablation system, prompting...
Breakthroughs in Aging and Protein Biology
New research sheds light on aging dynamics and protein stability. A comprehensive proteomic analysis identified a critical inflection point at approximately 50 years of age when aging accelerates,...
Industry Leadership Changes and Strategic Movements
Key leadership and strategic developments are shaping industry trajectories. Thermo Fisher Scientific announced CFO Stephen Williamson's upcoming retirement, succeeded by Jim Meyer. Agilent...
Sarepta’s Duchenne Gene Therapy Faces Regulatory and Market Setbacks
Sarepta Therapeutics’ gene therapy Elevidys for Duchenne muscular dystrophy (DMD) has encountered significant challenges in both U.S. and European regulatory arenas. The FDA requested Sarepta halt...
Novartis, Lilly, and Collaborators Fueling Innovation Through Strategic Deals
Biopharma giants are strengthening pipelines through collaboration and investment. Novartis agreed to a $60 million upfront deal with Matchpoint Therapeutics to develop oral covalent inhibitors...